Heterocyclic pyrazoline’s derivatives exhibiting promising potential antidiabetic activity

Abdallah MH, Abu Lila AS, El-Nahas HM, Ibrahim TM. 2023. Optimization of potential nanoemulgels for boosting transdermal glimepiride delivery and upgrading its anti-diabetic activity. Gels 9(6), 494.

Afzal HR, Khan NUH, Sultana K, Mobashar A, Lareb A, Khan A. 2021. Schiff bases of pioglitazone provide better antidiabetic and potent antioxidant effect in a streptozotocin–nicotinamide-induced diabetic rodent model. ACS Omega 6(6), 4470–4479.

Ahangarpour A, Heidari H, Shamsi F, Mard SA, Hashemitabar M. 2014. Antihyperglycemic and antioxidant effects of Rutin on diabetic rats. African Journal of Pharmacy and Pharmacology 8(4), 97–103.

Ahmed F, Haque M, Islam T, Hasan M. 2022. Synthesis and in vivo antidiabetic activity of novel 1,3,4-oxadiazole derivatives. Chemical Biology & Drug Design 100(3), 254–263.

Aksöz BE, Gürpınar SS, Eryılmaz M. 2020. Antimicrobial activities of some pyrazoline and hydrazone derivatives. Turkish Journal of Pharmaceutical Sciences 17(5), 500.

Ali F, Rahul, Naz F, Jyoti S, Siddique YH. 2014. Health functionality of Rutin: A review. International Journal of Biological Macromolecules 77, 508–516.

Araújo RL, Neto JL, Fulco UL, Oliveira JIN, Lyra ML, Manzoni V. 2023. DFT investigation of the solid-state properties and Hirshfeld surface analysis of antidiabetic drugs: acetohexamide and tolazamide. Chemical Physics Letters 833, 140934.

Bailey CJ, Krentz AJ. 2024. Oral glucose‐lowering agents. Textbook of Diabetes, 492–519.

Baynes K. 2022. Diabetes mellitus, obesity, lipoprotein disorders and other metabolic diseases. Medicine for Finals and Beyond, CRC Press, 429–470.

Bhutani R, Pathak DP, Kapoor G, Husain A, Kant R, Iqbal MA. 2018. Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model. Bioorganic Chemistry 77, 6–15.

Boudjou S, Oomah BD, Zaidi F, Hosseinian F. 2013. Phenolics content and antioxidant and antidiabetic activities of Spartium junceum L. Molecules 18(8), 10069–10081.

Chatterjee S, Pal A, Mandal M, Chakraborty T. 2023. Synthesis and biological evaluation of new coumarin derivatives for antidiabetic activity. Journal of Enzyme Inhibition and Medicinal Chemistry 38(1), 2173902.

Chen YC, Shen SC, Lee WR, Hsu FL. 2001. Rutin and quercetin suppress the progression of type II diabetes in a high-fat diet-induced obese C57BL/6J mouse model. European Journal of Pharmacology 673(1–3), 34–42.

Choudhary P, Tiwari R, Singh J. 2024. Development and biological evaluation of novel oxadiazole derivatives for antidiabetic activity. Medicinal Chemistry Research 33(1), 105–115.

Choudhury H, Pandey M, Hua CK, Mun CS, Jing JK, Kong L. 2018. An update on natural compounds in the remedy of diabetes mellitus: A systematic review. Journal of Traditional and Complementary Medicine 8(3), 361–376.

Das A, Sinha K, Chakrabarty S. 2024. Elucidating the molecular mechanism of noncompetitive inhibition of acetylcholinesterase by an antidiabetic drug chlorpropamide: identification of new allosteric sites. Physical Chemistry Chemical Physics 26(46), 28894–28903.

Devi R, Vijayakumar S, Gokila Vani M, Prakash S. 2011. In vitro antioxidant activity of Rutin and its effect on oxidative stress in rats. International Journal of Pharmaceutical Sciences and Research 2(3), 734–740.

Dey B, Dutta S, Shah BA, Panda A, Maji A, Jana S. 2019. Design and synthesis of benzimidazole-based thiadiazole derivatives and evaluation of their antidiabetic activities in streptozotocin-induced diabetic rats. Journal of Chemistry 2019, 1–14.

Dkhil MA, Al-Quraishy S, Diab MM, Othman MS, Aref AM. 2015. The potential role of Rutin in ameliorating diabetic cardiomyopathy in rats. Journal of Medicinal Food 18(7), 728–736.

Duhan M, Singh R, Devi M, Sindhu J, Bhatia R, Kumar A, Kumar P. 2021. Synthesis, molecular docking and QSAR study of thiazole clubbed pyrazole hybrid as α-amylase inhibitor. Journal of Biomolecular Structure and Dynamics 39(1), 91–107.

Elgohary MK, Abd El Hadi SR, Abo-Ashour MF, Abo-El Fetoh ME, Afify H, Abdel-Aziz HA, Abou-Seri SM. 2023. Fragment merging approach for the design of thiazole/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents. Bioorganic Chemistry 139, 106724.

Elmalahany NS, Abdel-Tawab MAH, Elwy HM, Fahmy HM, El Nashar RM. 2023. Design and application of molecularly imprinted electrochemical sensor for the new generation antidiabetic drug saxagliptin. Electroanalysis 35(5), e202200313.

Foroumadi R, Baeeri M, Asgarian S, Emamgholipour Z, Goli F, Firoozpour L. 2022. Antidiabetic and neuroprotective effects of a novel repaglinide analog. Journal of Biochemical and Molecular Toxicology 36(9), e23125.

Ganavi D, Ramu R, Kumar V, Patil SM, Martiz RM, Shirahatti PS, Shivachandra JC. 2022. In vitro and in silico studies of fluorinated 2,3-disubstituted thiazolidinone-pyrazoles as potential α-amylase inhibitors and antioxidant agents. Archiv der Pharmazie 355(3), 2100342.

García-Mediavilla MV, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, Tuñón MJ, González-Gallego J. 2007. The anti-inflammatory flavones Rutin and Hesperidin present in citrus fruits inhibit iNOS and COX-2 expression in rat hepatocytes via NF-κB pathway. Nutrition and Cancer 59(2), 267–273.

Haddad D, Belboukhari N, Sekkoum K, Bouanini M. 2024. Determination of the structural parameters of repaglinide in tablet: an antidiabetic drug, using spectroscopic methods. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences 4(2), 75–81.

Haider K, Shafeeque M, Yahya S, Yar MS. 2022. A comprehensive review on pyrazoline-based heterocyclic hybrids as potent anticancer agents. European Journal of Medicinal Chemistry Reports 5, 100042.

Haque SM. 2024. Current analytical methods and their limitations in quantifying antidiabetic drug nateglinide and repaglinide in pharmaceutical formulations and biological fluids. Yanbu Journal of Engineering and Science 21(2), 74–91.

Harit T, Cherfi M, Elhouda Daoudi N, Isaad J, Bnouham M, Malek F. 2022. Hybrid pyrazole‐tetrazole derivatives with high α‐amylase inhibition activity: synthesis, biological evaluation and docking study. ChemistrySelect 7(48), e202203757.

Hassan AS, Morsy NM, Aboulthana WM, Ragab A. 2023. In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: Design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulation. Drug Development Research 84(1), 3–24.

HM AB, Dubey S. 2024. Fundamental chemistry of N-heterocycles: Pyrrole and pyrazole chemistry, imidazole chemistry, triazole chemistry. Advances in Heterocyclic Ring Systems, 64.

Hossain MJ, Sultan MZ, Rashid MA, Kuddus MR. 2020. Does rabeprazole sodium alleviate the anti-diabetic activity of linagliptin? Drug-drug interaction analysis by in vitro and in vivo methods. Drug Research 70(11), 519–527.

Ibraheem F, Ahmad M, Ashfaq UA, Aslam S, Ali Khan Z, Sultan S. 2020. Synthesis, molecular docking and anti-diabetic studies of novel benzimidazole-pyrazoline hybrid molecules.

Ikram M, Park TJ, Ali T, Kim MO. 2018. Antioxidant and neuroprotective effects of Rutin against oxidative stress–induced neuroinflammation in Alzheimer’s disease. Journal of Neuroimmune Pharmacology 13, 503–521.

Islam MS, Al-Majid AM, Sholkamy EN, Yousuf S, Ayaz M, Nawaz A, Barakat A. 2022. Synthesis, molecular docking and enzyme inhibitory approaches of some new chalcones engrafted pyrazole as potential antialzheimer, antidiabetic and antioxidant agents. Journal of Molecular Structure 1269, 133843.

Jain S, Sharma MK, Syed A, Bahkali AH, Nimesh S, Gupta N, Chatterjee S. 2024. Synergistic therapeutic effect of Guggul gum resin on antidiabetic activity of saxagliptin. Journal of Agriculture and Food Research 18, 101462.

Jain SK, Singhal R. 2020. A review on pyrazoline derivatives as antimicrobial agent. International Journal of Pharmacy and Pharmaceutical Sciences 12(6), 15–24.

Janbaz KH, Qadir MI, Ahmad B, Saeed SA, Gilani AH. 2014. Antioxidant potential and protective effect of Rutin against carbon tetrachloride-induced liver injury in rats. Bangladesh Journal of Pharmacology 9(3), 315–321.

Johnson M, Smith R, Lee H. 2023. Design and biological evaluation of new heterocyclic compounds as antidiabetic agents. European Journal of Medicinal Chemistry 245, 114834.

Kadan S, Sasson Y, Saad B, Zaid H. 2016. Rutin, a natural flavonoid with potential antidiabetic properties. European Journal of Pharmacology 791, 38–44.

Kale I, Patil J, Shingane S. 2024. Preparation evaluation of microspheres of nateglinide for the treatment of diabetes mellitus. Research Journal of Pharmacology and Pharmacodynamics 16(3), 156–160.

Kapoor N, Gupta A, Verma R. 2024. Novel benzothiazole derivatives as potent antidiabetic agents: synthesis, biological evaluation, and molecular docking studies. Chemical Biology & Drug Design 103(3), 289–299.

Kazmi I, Afzal M, Rahman M, Saleem S, Khan A, Ashraf M. 2012. Anti-diabetic and antihyperlipidemic effects of Rutin in streptozotocin-induced diabetic rats. Indian Journal of Experimental Biology 50, 419–424.

Kazmi M, Zaib S, Ibrar A, Amjad ST, Shafique Z, Mehsud S, Khan I. 2018. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Bioorganic Chemistry 77, 190–202.

Khan H, Zamir A, Imran I, Saeed H, Alqahtani F, Majeed A. 2024. Clinical pharmacokinetics of glipizide: a systematic review. Expert Opinion on Drug Metabolism & Toxicology, 1–11.

Khan MF. 2024. Diabetes and antidiabetic drugs. In: Medicinal Chemistry for Pharmacy Students. Bentham Science Publishers, 220–294.

Kostyuk VA, Potapovich AI, Suhan TO, de Luca C, Korkina LG. 2011. Antioxidant and signal-modulating properties of plant polyphenols in controlling vascular inflammation. European Journal of Pharmacology 658(2–3), 248–256.

Kumar A, Kumar P, Shetty CR, James JP, Shetty HC. 2021. Synthesis, antidiabetic evaluation and bioisosteric modification of quinoline incorporated 2-pyrazoline derivatives. Indian Journal of Pharmaceutical Education and Research 55(2), 574–580.

Kumar S, Narwal S, Kumar V, Prakash O. 2011. α-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacognosy Reviews 5(9), 19–29.

Kumbhare RM, Sivakumar T, Lobo R, Parasuraman S. 2012. In vitro antioxidant and antiglycation activity of Rutin and quercetin in albumin glycation model. Pharmacognosy Research 4(3), 195–199.

La Casa C, Villegas I, Alarcon de la Lastra C, Motilva V, Martin Calero MJ. 2000. Evidence for protective and antioxidant properties of Rutin, a natural flavone, against ethanol-induced gastric lesions. Journal of Ethnopharmacology 71(1–2), 45–53.

Lee HM, Yoon SH, Kim MG, Hahn SJ, Choi BH. 2023. Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels. The Korean Journal of Physiology & Pharmacology 27(1), 95–103.

Lee SH, Park JS, Lee JH, Kim MS. 2023. Synthesis and biological evaluation of indole-based compounds as antidiabetic agents. Bioorganic & Medicinal Chemistry Letters 59, 128562.

Lee Y, Kim S, Lee J. 2023. Synthesis and antidiabetic evaluation of novel 2-phenylimidazo[1,2-a]pyridine derivatives. Medicinal Chemistry Research 32(10), 1190–1201.

Li X, Zhou D, Liu M, Zeng H, Yu X, Song Y, et al. 2024. Evaluation of anti-diabetic effects of glimepiride/metformin cocrystal. Journal of Drug Targeting, 1–13.

Majid N, Siddiqi MK, Hassan MN, Malik S, Khan S, Khan RH. 2023. Inhibition of primary and secondary nucleation along with disruption of amyloid fibrils and alleviation of associated cytotoxicity: a biophysical insight of a novel property of chlorpropamide (an anti-diabetic drug). Biomaterials Advances 151, 213450.

Majid N, Siddiqi MK, Hassan MN, Malik S, Khan S, Khan RH. 2023. Inhibition of primary and secondary nucleation along with disruption of amyloid fibrils and alleviation of associated cytotoxicity: a biophysical insight of a novel property of chlorpropamide (an anti-diabetic drug). Biomaterials Advances 151, 213450.

Mamun-Or-Rashid ANM, Hossain CF, Islam MN, Hossain MA, Saha A, Mosaddik MA. 2014. Antinociceptive and antioxidant activity of Rutin isolated from the methanolic extract of Vitex negundo Linn leaves. Medicinal Plants – International Journal of Phytomedicines and Related Industries 6(2), 100–105.

Manickam M, Ananthi P. 2022. Synthesis, characterization, and in silico analysis of 1,2,4-triazole derivatives for antidiabetic activity. Journal of Chemical Sciences 134(3), 45.

Mantzanidou M, Pontiki E, Hadjipavlou-Litina D. 2021. Pyrazoles and pyrazolines as anti-inflammatory agents. Molecules 26(11), 3439.

Matiadis D, Sagnou M. 2020. Pyrazoline hybrids as promising anticancer agents: An up-to-date overview. International Journal of Molecular Sciences 21(15), 5507.

Mohajan D, Mohajan HK. 2024. Oral hypoglycaemic agents: Non-insulin medications for type 2 diabetes patients. Innovation in Science and Technology 3(1), 23–31.

Mohanty D, Gilani SJ, Zafar A, Imam SS, Kumar LA, Ahmed MM. 2022. Formulation and optimization of alogliptin-loaded polymeric nanoparticles: In vitro to in vivo assessment. Molecules 27(14), 4470.

Mor S, Khatri M. 2022. Synthesis, antimicrobial evaluation, α-amylase inhibitory ability and molecular docking studies of 3-alkyl-1-(4-(aryl/heteroaryl) thiazol-2-yl) indeno[1,2-c] pyrazol-4(1H)-ones. Journal of Molecular Structure 1249, 131526.

Mukherjee S, Maity S, Ghosh B, Chakraborty T, Mondal A, Bishayee A. 2020. Assessment of the antidiabetic potentiality of glyburide loaded glyceryl monostearate solid lipid nanoparticles. Journal of Drug Delivery Science and Technology 55, 101451.

Nagulancha BR, Vandavasi KR. 2023. Stability-indicating method development and validation for quantitative estimation of organic impurities of the antidiabetic drug glipizide in drug substance and pharmaceutical dosage form using HPLC. Biomedical Chromatography 37(11), e5727.

Nasab NH, Azimian F, Eom YS, Shah FH, Kim SJ. 2023. Synthesis, anticancer evaluation, and molecular docking studies of thiazolyl-pyrazoline derivatives. Bioorganic & Medicinal Chemistry Letters 80, 129105.

Niture NT, Ansari AA, Naik SR. 2014. Anti-hyperglycemic activity of Rutin in alloxan-induced diabetic rats: An in vivo and in silico study. Journal of Traditional and Complementary Medicine 4(3), 176–185.

Oulous A, Daoudi NE, Harit T, Cherfi M, Bnouham M, Malek F. 2022. New pyrazole-tetrazole hybrid compounds as potent α-amylase and non-enzymatic glycation inhibitors. Bioorganic & Medicinal Chemistry Letters 69, 128785.

Pandit S, Upadhyay R, Trivedi J, Patel D, Shah J, Patel K. 2021. Synthesis and biological evaluation of novel thiazolidinone derivatives as potent antidiabetic agents. Medicinal Chemistry Research 30(6), 917–927.

Park SH, Ham JR, Lee HI, Choi RY, Yoon YM, Lee MK. 2021. Rutin from Morus alba alleviates nonalcoholic steatohepatitis in diet-induced obese mice. Journal of Nutritional Biochemistry 97, 108802.

Patel S, Shah R, Patel P, Parmar P. 2023. Molecular docking and synthesis of novel pyrazole derivatives as potent antidiabetic agents. Medicinal Chemistry Research 32(5), 763–771.

Patel V, Shah S, Patel N. 2023. Synthesis and antidiabetic evaluation of novel thiazole derivatives in streptozotocin-induced diabetic rats. Journal of Pharmacy and Pharmacology 75(3), 410–420.

Patil RH, Maheshwari VL. 2013. Rutin supplementation attenuates oxidative stress and improves mitochondrial function in streptozotocin-nicotinamide-induced diabetic rats. International Journal of Green Pharmacy 7(4), 273–279.

Patil RH, Prakash K, Maheshwari VL. 2013. Hypoglycemic and antihyperglycemic effect of Rutin on alloxan induced diabetic rats. International Journal of Research in Ayurveda and Pharmacy 4(2), 176–179.

Prabu SM, Shagirtha K. 2012. Cardioprotective effect of Rutin on isoproterenol-induced myocardial infarction in rats. Molecular and Cellular Biochemistry 365(1–2), 93–101.

Ramachandran S, Ramesh C, Kumar S. 2023. Discovery of new thiazolidinedione analogs as potent PPARγ agonists for type 2 diabetes treatment. European Journal of Pharmacology 931, 175198.

Rana M, Arif R, Khan FI, Maurya V, Singh R, Faizan MI. 2021. Pyrazoline analogs as potential anticancer agents. Bioorganic Chemistry 108, 104665.

Rani N, Bharti S, Manchanda M, Nag TC, Ray R, Chauhan SS, Arya DS. 2016. Pharmacological properties of Rutin in diabetes mellitus: An overview. Indian Journal of Biochemistry & Biophysics 53, 38–52.

Razzaq FA, Asif M, Asghar S, Iqbal MS, Khan IU, Khan SUD. 2021. Glimepiride-loaded nanoemulgel; development, in vitro characterization, ex vivo permeation and in vivo antidiabetic evaluation. Cells 10(9), 2404.

Roy S, Dutta S, Manna S. 2023. Synthesis, characterization, and in vivo evaluation of novel quinoline derivatives as antidiabetic agents. Bioorganic Chemistry 148, 106045.

Saeed N, Khan MR, Shabbir M. 2012. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts of Torilis leptophylla L. BMC Complementary and Alternative Medicine 12, 221.

Saeedan AS, Soliman GA, Abdel-Rahman RF, Abd-Elsalam RM, Ogaly HA, Alharthy KM, Abdel-Kader MS. 2021. Possible synergistic antidiabetic effects of quantified Artemisia judaica extract and glyburide in streptozotocin-induced diabetic rats via restoration of PPAR-α mRNA expression. Biology 10(8), 796.

Saha P. 2020. Evolution of tolbutamide in the treatment of diabetes mellitus. Diabetes 2(10).

Selvaraj S, Krishnaswamy S, Devashya V, Ramesh M, Ravikumar P. 2013. Protective role of Rutin and naringin in glyoxal induced renal damage. Chemico-Biological Interactions 204(3), 209–218.

Shah R, Patel K, Shah P, Parmar P. 2022. Design, synthesis, and antidiabetic activity evaluation of novel quinazoline derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry 37(1), 765–774.

Shahwan M, Alhumaydhi F, Ashraf GM, Hasan PM, Shamsi A. 2022. Role of polyphenols in combating type 2 diabetes. International Journal of Biological Macromolecules 206, 567–579.

Sharma A, Gautam A, Kumar D, Kumar N, Kothiyal P, Sharma S. 2022. Synthesis of novel imidazo[2,1-b]thiazol-5(4H)-one derivatives as prospective antidiabetic agents. Future Journal of Pharmaceutical Sciences 8(1), 35.

Sharma M, Nazareth RL. 2021. Rutin, a therapeutic supplement for diabetes mellitus: Review of evidence. Journal of Applied Pharmaceutical Science 11(1), 147–153.

Singh D, Jayaram R, Jena SS. 2022. Effect of dietary phytochemicals in diabetes mellitus: A review. Current Nutrition & Food Science 18(5), 520–531.

Singh R, Kumar D, Kumar P, Singh S. 2024. Design and synthesis of novel imidazopyridine derivatives as alpha-glucosidase inhibitors. Bioorganic Chemistry 147, 105946.

Smith J, Brown L, Nguyen T, Lee H, Kim Y. 2024. Development of novel sulfonylurea derivatives with improved efficacy and safety profiles for type 2 diabetes mellitus. European Journal of Medicinal Chemistry 245, 114877.

SS PKP, Nandyala S, Anjali A, Mullangi P. 2024. Development and pharmacological evaluation of floating drug delivery system of tolbutamide. Frontier Journal of Pharmaceutical Sciences and Research 7(2), 6–11.

Subramanian R, Asmawi MZ, Sadikun A. 2008. In vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochimica Polonica 55(2), 391–398.

Sultana R, Anwar T, Mushtaq G, Choudhry H, Abdulrahman ST, Alhazza IM. 2020. Rutin as a promising therapeutic option in managing neurodegenerative disorders. Current Drug Metabolism 21(2), 118–126.

Taha M, Imran S, Rahim F, Wadood A, Hussain R, Ali F. 2021. Pharmacological evaluation of novel pyrimidine, oxadiazole, and thiadiazole derivatives as antidiabetic agents: synthesis, molecular docking, and in vivo studies. Drug Design, Development and Therapy 15, 4591–4605.

Tamimi LN, Zakaraya Z, Hailat M, Dayyih WA, Daoud E, Abed Ay. 2023. Anti-diabetic effect of cotreatment with resveratrol and pioglitazone in diabetic rats. European Review for Medical and Pharmacological Sciences 27, 325–332.

Thilagavathi R, Hosseini‐Zare MS, Malini M, Selvam C. 2022. A comprehensive review on glucokinase activators. Chemical Biology & Drug Design 99(2), 247–263.

TN MM, Snigdha K, Asiri AM, Sobahi TR, Asad M. 2023. Green synthesis of chromonyl chalcone and pyrazoline as potential antimicrobial agents. Journal of Molecular Structure 1271, 133993.

Uğraş Z, Tok F, Çakir C, Tuna K, Tatar-Yılmaz G, Mutlu D. 2024. Exploring 2-pyrazoline derivatives as potent antidiabetic agents. Journal of Molecular Structure 1315, 138978.

Vázquez C, Encalada R, Jiménez-Galicia I, Gómez-Escobedo R, Rivera G, Nogueda-Torres B, Saavedra E. 2024. Repurposing the antidiabetic drugs glyburide, gliquidone, and glipizide in combination with benznidazole for Trypanosoma cruzi infection. Pharmaceuticals 18(1), 21.

Verma P, Singh S, Gupta A. 2023. Design and synthesis of novel indole derivatives as antidiabetic agents targeting PPARγ. European Journal of Pharmacology 940, 175362.

Weinberg Sibony R, Segev O, Dor S, Raz I. 2023. Drug therapies for diabetes. International Journal of Molecular Sciences 24(24), 17147.

Xu B, Xing A, Li S. 2022. The forgotten type 2 diabetes mellitus medicine: rosiglitazone. Diabetology International 13(1), 49–65.

Yan R, Huang X, Deng X, Song M. 2022. Synthesis and activity evaluation of some pyrazole–pyrazoline derivatives as dual anti-inflammatory and antimicrobial agents. Polycyclic Aromatic Compounds 42(8), 5006–5019.

Zhang Y, Wang X, Chen X, Li L, Zhou Z. 2023. Design, synthesis, and evaluation of a new series of dipeptidyl peptidase-IV inhibitors for the treatment of type 2 diabetes. Bioorganic Chemistry 135, 106275.

Zhao Y, Chen S, Pan X, Zhang Y, Zeng X, Zhang H. 2012. Anti-diabetic effects of flavonoids from Sophora flavescens in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 144(2), 371–378.